Natural autoantibodies and associated B cells in immunity and autoimmunity

References

• Guilbert B., Dighiero G., Avrameas S.. Naturally occuring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J. Immunol. 1982; 128:2779–2787.
   PubMed Web of Science ®Google Scholar
• Dighiero G., Lymberi P., Mazie J. C., . Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J. Immunol. 1983; 131:2267–2272.
   PubMed Web of Science ®Google Scholar
• Dighiero G., Lymberi P., Guilbert B., Ternynck T., Avrameas S.. Natural autoantibodies constitute a substantial part of normal circulating immunoglobulin. Ann. N.Y. Acad. Sci. 1986; 475:135–145.
   PubMed Web of Science ®Google Scholar
• Coutinho A., Kazatchkine M. D., Avrameas S.. Natural autoantibodies. Curr. Opin. Immunol. 1995; 7:812–818.
   PubMed Web of Science ®Google Scholar
• Avrameas S.. Natural autoantibodies: from horror autotoxicus to gnothi seauton. Immunol. Today. 1991; 12:54.
   PubMedGoogle Scholar
• Haspel M. V., Onodera T., Prabhakar B. S., . Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science. 1983; 220:304–306.
   PubMed Web of Science ®Google Scholar
• Haspel M. V., Onodera T., Prabhakar B. S., . Multiple organ-reactive monoclonal autoantibodies. Nature. 1983; 304:73–76.
   PubMed Web of Science ®Google Scholar
• Satoh J., Prabhakar B. S., Haspel M. V., Ginsberg-Fellner F., Notkins A. L.. Human monoclonal autoantibodies that react with multiple endocrine organs. N. Engl. J. Med. 1983; 309:217–220.
   Google Scholar
• Casali P., Notkins A.. CD5+B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today. 1989; 10:364–368.
   PubMedGoogle Scholar
• Mouthon L., Nobrega A., Nicolas N., . Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc. Natl. Acad. Sci. USA. 1995; 92:3839–3843.
   PubMed Web of Science ®Google Scholar
• Chen Z. J., Wheeler C. J., Shi W., . Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur. J. Immunol. 1998; 28:989–994.
   PubMed Web of Science ®Google Scholar
• Merbl Y., Zucker-Toledano M., Quintana F., Cohen I.. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J. Clin. Invest. 2007; 117:712–718.
   PubMed Web of Science ®Google Scholar
• Dighiero G., Lymberi P., Holmberg D., . High frequency of natural autoantibodies in normal newborn mice. J. Immunol. 1985; 134:765–771.
   PubMed Web of Science ®Google Scholar
• Hooijkaas H., Benner R., Pleasants J. R., Wostmann B. S.. Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered “antigenfree” diet. Eur. J. Immunol. 1984; 14:1127–1130.
   PubMedGoogle Scholar
• Wardemann H., Yurasov S., Schaefer A., . Predominant autoantibody production by early human B cell precursors. Science. 2003; 301 5638: 1374–1377.
   PubMed Web of Science ®Google Scholar
• Gonzalez R., Charlemagne J., Mahana W., Avrameas S.. Specificity of natural serum antibodies present in phylogenetically distinct fish species. Immunology. 1988; 63:31–36.
   PubMedGoogle Scholar
• Flajnik M., Rumfelt L.. Early and natural antibodies in non-mammalian vertebrates. Curr. Top. Microbiol. Immunol. 2000; 252:233–240.
   PubMedGoogle Scholar
• Souroujon M., White-Scharf M. E., Andreschwartz J., Gefter M. L., Schwartz R. S.. Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J. Immunol. 1988; 140:4173–4179.
   PubMed Web of Science ®Google Scholar
• Notkins A. L.. Polyreactivity of antibody molecules. Trends Immunol.. 2004; 25:174–179.
   PubMed Web of Science ®Google Scholar
• Chen C., Stenzel-Poore M. P., Rittenberg M. B.. Natural auto- and polyreactive antibodies differing from antigen-induced antibodies in the H chain CDR3. J. Immunol. 1991; 147:2359–2367.
   PubMed Web of Science ®Google Scholar
• Poncet P., Matthes T., Billecocq A., Dighiero G.. Immunochemical studies of polyspecific natural autoantibodies: charge, lipid reactivity, Fab’2 fragment activity and complement fixation. Mol. Immunol. 1988; 25:981.
   PubMed Web of Science ®Google Scholar
• Fernandez P.-A., Ternynck T., Avrameas S.. Immunochemical studies of a murine polyreactive IgG2b autoantibody with rheumatoid factor activity. Mol. Immunol. 1989; 26:539.
   PubMed Web of Science ®Google Scholar
• Bona C. A.. V genes encoding autoantibodies: molecular and phenotypic characteristics. Ann. Rev. Immunol. 1988; 6:327.
   PubMed Web of Science ®Google Scholar
• Baccala R., Quang T. V., Gilbert M., Ternynck T., Avrameas S.. Two murine natural polyreactive autoantibodies are encoded by nonmutated germline genes. Proc. Natl. Acad. Sci. USA. 1989; 86:4624.
   PubMed Web of Science ®Google Scholar
• Kofler R., Dixon F. J., Theofilopoulos A. N.. The genetic origin of autoantibodies. Immunol. Today. 1987; 8:374.
   PubMedGoogle Scholar
• Hartman A. B., Mallett C. P., Srinivasappa J., . Organ reactive autoantibodies from non-immunized adult BALB/c mice are polyreactive and express non-biased VH gene usage. Mol. Immunol. 1989; 26:359–370.
   PubMed Web of Science ®Google Scholar
• Ichiyoshi Y., Casali P.. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J. Exp. Med. 1994; 180:885–895.
   PubMed Web of Science ®Google Scholar
• Ichiyoshi Y., Casali P.. Analysis of the structural correlates for self-antigen binding by natural and disease-related autoantibodies. In vitro expression of recombinant and/or mutagenized human IgG. Ann N Y Acad Sci. 1995; 764:328–341.
   PubMed Web of Science ®Google Scholar
• Casali P., Schettino E. W.. Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol. 1996; 210:167–179.
   PubMed Web of Science ®Google Scholar
• Martin T., Crouzier R., Weber J. C., Kipps T. J., Pasquali J. L.. Structure-function studies on a polyreactive [natural] autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J. Immunol. 1994; 152:5988–5996.
   PubMed Web of Science ®Google Scholar
• Deng Y. J., Notkins A. L.. Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides. Clin. Exp. Immunol. 2000; 119:69–76.
   PubMedGoogle Scholar
• Amit A. G., Mariuzza R. A., Phillips S. E., Poljak R. J.. Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science. 1986; 233:747–753.
   PubMed Web of Science ®Google Scholar
• Segal D. M., Padlan E. A., Cohen G. H., . The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA. 1974; 71:4298–4302.
   PubMed Web of Science ®Google Scholar
• Martin F., Kearney J. F.. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”. Immunol. Rev. 2000; 175:7079.
   Google Scholar
• Hayakawa K., Hardy R. R., Parks D. R., Herzenberg L. A.. The “Ly-1” B cell subpopulation in normal, immunodefective, and autoimmune mice. J. Exp. Med. 1983; 157:202–218.
   PubMed Web of Science ®Google Scholar
• Kantor A. B., Herzenberg A.. Origin of murine B cell lineages. Annu. Rev. Immunol. 1993; 11:501–538.
   PubMed Web of Science ®Google Scholar
• Baumgarth N.. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol.11:34–46.
   PubMedGoogle Scholar
• Martin F., Kearney J. F.. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 2000; 12:39–49.
   PubMed Web of Science ®Google Scholar
• Pennell C. A., Arnold L. W., Haughton G., Clarke S. H.. Restricted Ig variable region gene expression among Ly-1+B cell hybridomas. J. Immunol. 1988; 141:2788–2796.
   PubMed Web of Science ®Google Scholar
• Tarlinton D., Stall A. M., Herzenberg L. A.. Repetitive usage of immunoglobulin VH and D gene segments in CD5+Ly-1 B clones of [NZB x NZW]F1 mice. EMBO J. 1988; 7:3705–3710.
   PubMed Web of Science ®Google Scholar
• Tornberg U. C., Holmberg D.. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressure. EMBO J. 1995; 14:1680–1689.
   PubMedGoogle Scholar
• Kantor A. B., Merrill C. E., Herzenberg L. A., Hillson J. L.. An unbiased analysis of VH-D-JH sequences from B-1a, B-1b and conventional B cells. J. Immunol. 1997; 158:1175–1186.
   PubMed Web of Science ®Google Scholar
• Gu H., Forster I., Rajewsky K.. Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cells and B-CLL progenitor generation. EMBO J. 1990; 9:2133.
   PubMed Web of Science ®Google Scholar
• Zhou Z. H., Notkins A. L.. Polyreactive antigen-binding B [PAB-] cells are widely distributed and the PAB population consists of both B-1+and B-1-phenotypes. Clin. Exp. Immunol. 2004; 137:88–100.
   PubMedGoogle Scholar
• Thurnheer M. C., Zuercher A. W., Cebra J. J., Bos N. A.. B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice. J. Immunol. 2003; 170:4564–4571.
   PubMedGoogle Scholar
• Nobrega A., Stransky B., Nicolas N., Coutinho A.. Regeneration of natural antibody repertoire after massive ablation of lymphoid system: robust selection mechanisms preserve antigen binding specificities. J. Immunol. 2002; 169:2971–2978.
   PubMed Web of Science ®Google Scholar
• Tian Q., Beardall M., Xu Y., . B cells expressing a natural polyreactive autoantibody have a distinct phenotype and are overrepresented in immunoglobulin heavy chain transgenic mice. J. Immunol. 2006; 177:2412–2422.
   PubMedGoogle Scholar
• Hayakawa K., Asano M., Shinton S. A., . Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 2003; 197:87–99.
   PubMed Web of Science ®Google Scholar
• Baumgarth N., Herman O. C., Jager G. C., Herzenberg L. A., Herzenberg L. A.. Innate and acquired immunities to influenza virus are provided by distinct B cells. Proc. Natl. Acad. Sci. USA. 1999; 96:2250–2255.
   PubMedGoogle Scholar
• Ochsenbein A. F., Fehr T., Lutz C.. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999; 286:2156–2159.
   PubMed Web of Science ®Google Scholar
• Baumgarth N., Herman O. C., Jager G. C., . B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 2000; 192:271–280.
   PubMed Web of Science ®Google Scholar
• Boes M., Prodeus A. P., Schmidt T., Carroll M. C., Chen J.. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 1998; 188:2380–2386.
   Google Scholar
• Diamond M. S., Sitati E. M., Friend L. D., . A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 2003; 198:1853–1862.
   PubMed Web of Science ®Google Scholar
• Rajan B., Ramalingam T., Rajan T. V.. Critical role for IgM in host protection in experimental filarial infection. J Immunol. 2005; 175:1827–1833.
   PubMed Web of Science ®Google Scholar
• Zhou Z. H., Zhang Y., Hu Y. F., . The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe. 2007; 1:51–61.
   PubMed Web of Science ®Google Scholar
• Jayasekera J. P., Moseman E. A., Carroll M. C.. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol. 2007; 81:3487–3494.
   PubMed Web of Science ®Google Scholar
• Rapaka R. R., Ricks D. M., Alcorn J. F., . Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J. Exp. Med207:2907–2919.
   PubMedGoogle Scholar
• Racine R., Winslow G. M.. IgM in microbial infections: taken for granted? Immunol. Lett. 2009; 125:79–85.
   Google Scholar
• Boes M.. Role of natural and immune IgM antibodies in immune responses. Mol. Immunol. 2000; 37:1141–1149.
   PubMed Web of Science ®Google Scholar
• Matejuk A., Beardall M., Xu Y., . Exclusion of natural autoantibody-producing B cells from IgG memory B cell compartment during T cell-dependent immune responses. J. Immunol. 2009; 182:7634–7643.
   PubMedGoogle Scholar
• Chen C., Roberts V., Rittenberg M.. Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen. J. Exp. Med. 1992; 176:855–866.
   PubMed Web of Science ®Google Scholar
• Chen C., Roberts V., Stevens S., . Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations. EMBO J. 1995; 14:2784–2794.
   PubMedGoogle Scholar
• Wiens G., Brown M., Rittenberg M.. Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function. J. Immunol. 2003; 170:5095–5102.
   PubMedGoogle Scholar
• Chen C., Martin T., Stevens S., Rittenberg M.. Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2. J. Exp. Med. 1994; 180:577–586.
   PubMedGoogle Scholar
• Xu Z., Pone E. J., Al-Qahtani A., . Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit. Rev. Immunol. 2007; 27:367–397.
   PubMed Web of Science ®Google Scholar
• McBride K. M., Gazumyan A., Woo E. M., . Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 2008; 205:2585–2594.
   PubMedGoogle Scholar
• Mannoor K., Matejuk A., Xu Y., Beardall M., Chen C.. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. J. Immunol188:3628–3638.
   PubMedGoogle Scholar
• Qin X. F., Schwers S., Yu W., . Secondary V[D]J recombination in B1 cells. Nature. 1999; 397:355–359.
   PubMedGoogle Scholar
• Yurasov S., Wardemann H., Hammersen J., . Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 2005; 201:703–711.
   PubMed Web of Science ®Google Scholar
• Samuels J., Ng Y., Coupillaud C., Paget D., Meffre E.. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 2005; 201:1659–1667.
   PubMed Web of Science ®Google Scholar
• Cook W. D., Rudikoff S., Giusti A. M., . Antigen binding variants of the S107 mouse myeloma cell line. Prog. Clin. Biol. Res. 1980; 42:217–230.
   PubMedGoogle Scholar
• Napastek Y., Andre-Schwartz J., Manser T., . A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J. Exp. Med. 1986; 164:614–626.
   PubMedGoogle Scholar
• Ikematsu H., Kasaian M. T., Schettino E. W., Casali P.. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J. Immunol. 1993; 151:3604–3616.
   PubMed Web of Science ®Google Scholar
• Boes M., Esau C., Fischer M. B., . Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 1998; 160:4776–4787.
   PubMed Web of Science ®Google Scholar
• Ehrenstein M. R., O'Keefe T. L., Davies S. L., Neuberger M. S.. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. USA. 1998; 95:10089–10093.
   PubMed Web of Science ®Google Scholar
• Ehrenstein M. R., Cook H. T., Neuberger M. S.. Deficiency in serum immunoglobulin [Ig]M predisposes to development of IgG autoantibodies. J. Exp. Med. 2000; 191:1253–1258.
   PubMed Web of Science ®Google Scholar
• Boes M., Schmidt T., Linkemann K., . Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA. 2000; 97:1184–1189.
   PubMed Web of Science ®Google Scholar
• Jiang C., Foley J., Clayton N., . Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 2007; 178:7422–7431.
   PubMed Web of Science ®Google Scholar
• Jiang C., Zhao M. L., Scearce R. M., Diaz M.. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum63:1086–1096.
   PubMedGoogle Scholar
• Werwitzke S., Trick D., Kamino K., . Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the [NZB x NZW]F1 mouse. Arthritis Rheum. 2005; 52:3629–3638.
   PubMed Web of Science ®Google Scholar
• Chen Y., Khanna S., Goodyear C. S., . Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 2009; 183:1346–1359.
   PubMed Web of Science ®Google Scholar
• Witte T., Hartung K., Sachse C., . IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group. Rheumatol. Int. 1998; 18:85–91.
   PubMedGoogle Scholar
• Forger F., Matthias T., Oppermann M., Becker H., Helmke K.. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus. 2004; 13:36–44.
   PubMed Web of Science ®Google Scholar
• Gronwall C., Akhter E., Oh C., . IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin. Immunol142:390–398.
   PubMedGoogle Scholar
• Su J., Hua X., Concha H., . Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology [Oxford]. 2008; 47:1144–1150.
   PubMed Web of Science ®Google Scholar
• Li Q. Z., Xie C., Wu T., . Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 2005; 115:3428–3439.
   PubMed Web of Science ®Google Scholar
• Neeli I., Richardson M. M., Khan S. N., . Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs. Mol. Immunol. 2007; 44:1914–1921.
   PubMedGoogle Scholar
• Casciola-Rosen L. A., Anhalt G., Rosen A.. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 1994; 179:1317–1330.
   PubMed Web of Science ®Google Scholar
• Cocca B. A., Cline A. M., Radic M. Z.. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 2002; 169:159–166.
   PubMed Web of Science ®Google Scholar
• Kalaaji M., Fenton K. A., Mortensen E. S., . Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int. 2007; 71:664–672.
   PubMed Web of Science ®Google Scholar
• Botto M., Dell'Agnola C., Bygrave A. E., . Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 1998; 19:56–59.
   PubMed Web of Science ®Google Scholar
• Taylor P. R., Carugati A., Fadok V. A., . A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 2000; 192:359–366.
   PubMed Web of Science ®Google Scholar
• Gommerman J. L., Carroll M. C.. Negative selection of B lymphocytes: a novel role for innate immunity. Immunol. Rev. 2000; 173:120–130.
   PubMedGoogle Scholar
• Scott R. S., McMahon E. J., Pop S. M., . Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001; 411:207–211.
   PubMed Web of Science ®Google Scholar
• Cline A. M., Radic M. Z.. Murine lupus autoantibodies identify distinct subsets of apoptotic bodies. Autoimmunity. 2004; 37:85–93.
   PubMed Web of Science ®Google Scholar
• Cline A. M., Radic M. Z.. Apoptosis, subcellular particles, and autoimmunity. Clin. Immunol. 2004; 112:175–182.
   PubMed Web of Science ®Google Scholar
• Radic M., Marion T., Monestier M.. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 2004; 172:6692–6700.
   PubMed Web of Science ®Google Scholar
• Quartier P., Potter P. K., Ehrenstein M. R., Walport M. J., Botto M.. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol. 2005; 35:252–260.
   PubMed Web of Science ®Google Scholar
• Kim S. J., Gershov D., Ma X., Brot N., Elkon K. B.. I-PLA[2] activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med. 2002; 196:655–665.
   PubMed Web of Science ®Google Scholar
• Ogden C. A., Kowalewski R., Peng Y., Montenegro V., Elkon K. B.. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity. 2005; 38:259–264.
   PubMed Web of Science ®Google Scholar
• Notley C. A., Brown M. A., Wright G. P., Ehrenstein M. R.. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol. 2011; 186:4967–4972.
   PubMedGoogle Scholar
• Chen Y., Park Y. B., Patel E., Silverman G. J.. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 2009; 182:6031–6043.
   PubMedGoogle Scholar
• Melero J., Tarrago D., Nunez-Roldan A., Sanchez B.. Human polyreactive IgM monoclonal antibodies with blocking activity against self-reactive IgG. Scand. J. Immunol. 1997; 45:393–400.
   Google Scholar
• Williams R. C.Jr, Malone C. C., Huffman G. R., . Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype [anti-F[ab’]2] system. J. Rheumatol. 1995; 22:1075–1085.
   PubMed Web of Science ®Google Scholar
• Rossi F., Dietrich G., Kazatchkine M. D.. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses. Immunol. Rev. 1989; 110:135–149.
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A.. Antigen-specific interactions between T and B cells. Nature. 1985; 314:537.
   PubMed Web of Science ®Google Scholar
• Joao C., Ogle B. M., Gay-Rabinstein C., Platt J. L., Cascalho M.. B cell-dependent TCR diversification. J. Immunol. 2004; 172:4709–4716.
   Google Scholar
• Tumanov A. V., Grivennikov S. I., Shakhov A. N., . Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 2003; 195:106–116.
   PubMedGoogle Scholar
• Harris D. P., Haynes L., Sayles P. C., . Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 2000; 1:475–482.
   PubMed Web of Science ®Google Scholar
• Lund F. E.. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 2008; 20:332–338.
   PubMed Web of Science ®Google Scholar
• Eynon E. E., Parker D. C.. Small B cells as antigen presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 1992; 175:131.
   PubMed Web of Science ®Google Scholar
• Melo M. E., Qian J., El-Amine M., . Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol. 2002; 168:4788–4795.
   PubMed Web of Science ®Google Scholar
• Dalai S. K., Mirshahidi S., Morrot A., Zavala F., Sadegh-Nasseri S.. Anergy in memory CD4+T cells is induced by B cells. J. Immunol. 2008; 181:3221–3231.
   PubMedGoogle Scholar
• Frommer F., Heinen T. J., Wunderlich F. T., . Tolerance without clonal expansion: selfantigen-expressing B cells program self-reactive T cells for future deletion. J. Immunol. 2008; 181:5748–5759.
   PubMedGoogle Scholar
• Notkins A. L.. Polyreactive antibodies and polyreactive antigen-binding B [PAB] Cells. Curr. Top. Microbiol. Immunol. 2000; 252:241–249.
   PubMedGoogle Scholar
• Mizoguchi A., Bhan A. K.. A case for regulatory B cells. J Immunol. 2006; 176:705–710.
   PubMed Web of Science ®Google Scholar
• Mauri C., Ehrenstein M. R.. The ’short’ history of regulatory B cells. Trends Immunol. 2008; 29:34–40.
   PubMed Web of Science ®Google Scholar
• Fillatreau S., Gray D., Anderton S. M.. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 2008; 8:391–397.
   PubMed Web of Science ®Google Scholar
• Bouaziz J. D., Yanaba K., Tedder T. F.. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 2008; 224:201–214.
   PubMed Web of Science ®Google Scholar
• Jamin C., Morva A., Lemoine S., . Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum. 2008; 58:1900–1906.
   PubMed Web of Science ®Google Scholar
• Blair P. A., Norena L. Y., Flores-Borja F., . CD19[+]CD24[hi]CD38[hi] B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity32:129–140.
   PubMedGoogle Scholar
• Wolf S. D., Dittel B. N., Hardardottir F., Janeway C. A.Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996; 184:2271–2278.
   PubMed Web of Science ®Google Scholar
• Fillatreau S., Sweenie C. H., McGeachy M. J., Gray D., Anderton S. M.. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002; 3:944–950.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A., Mizoguchi E., Smith R. N., Preffer F. I., Bhan A. K.. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 1997; 186:1749–1756.
   PubMed Web of Science ®Google Scholar
• Wei B., Velazquez P., Turovskaya O., . Mesenteric B cells centrally inhibit CD4+T cell colitis through interaction with regulatory T cell subsets. Proc. Natl. Acad. Sci. USA. 2005; 102:2010–2015.
   PubMed Web of Science ®Google Scholar
• Mauri C., Gray D., Mushtaq N., Londei M.. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 2003; 197:489–501.
   PubMed Web of Science ®Google Scholar
• Evans J. G., Chavez-Rueda K. A., Eddaoudi A., . Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 2007; 178:7868–7878.
   PubMed Web of Science ®Google Scholar
• Hussain S., Delovitch T. L.. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J. Immunol. 2007; 179:7225–7232.
   PubMed Web of Science ®Google Scholar
• Blair P. A., Chavez-Rueda K. A., Evans J. G., . Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 2009; 182:3492–3502.
   PubMed Web of Science ®Google Scholar
• Ho A. S., Moore K. W.. Interleukin-10 and its receptor. Ther. Immunol. 1994; 1:173–185.
   PubMedGoogle Scholar
• Tian J., Zekzer D., Hanssen L., . Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 2001; 167:1081–1089.
   PubMed Web of Science ®Google Scholar
• Lampropoulou V., Hoehlig K., Roch T., . TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 2008; 180:4763–4773.
   PubMed Web of Science ®Google Scholar
• Brummel R., Lenert P.. Activation of marginal zone B cells from lupus mice with type A[D] CpG-oligodeoxynucleotides. J. Immunol. 2005; 174:2429–2434.
   PubMed Web of Science ®Google Scholar
• Leadbetter E., Rifkin I., Hohlbaum A., . Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002; 416:603–607.
   PubMed Web of Science ®Google Scholar
• Viglianti G. A., Lau C. M., Hanley T. M., . Activation of autoreactive B cells by CpG dsDNA. Immunity. 2003; 19:837–847.
   PubMed Web of Science ®Google Scholar
• Chen X., Jensen P. E.. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+CD4 T cells. J. Immunol. 2007; 179:2046–2050.
   PubMedGoogle Scholar
• Kazatchkine M. D., Kaveri S. V.. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 2001; 345:747–755.
   PubMed Web of Science ®Google Scholar
• Jordan S. C., Toyoda M., Vo A. A.. Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation. 2009; 88:1–6.
   PubMed Web of Science ®Google Scholar
• Hurez V., Kazatchkine M. D., Vassilev T., . Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood. 1997; 90:4004–4013.
   PubMed Web of Science ®Google Scholar
• Rieben R., Roos A., Muizert Y., . Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood. 1999; 93:942–951.
   PubMed Web of Science ®Google Scholar
• Zander A. R., Zabelina T., Kroger N., . Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow. Bone Marrow Transplant. 1999; 23:889–893.
   PubMedGoogle Scholar
• Shoenfeld Y., Rauova L., Gilburd B., . Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus. Int. Immunol. 2002; 14:1303–1311.
   PubMed Web of Science ®Google Scholar